Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 14 von 78

Details

Autor(en) / Beteiligte
Titel
A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunity
Ist Teil von
  • iScience, 2022-10, Vol.25 (10), p.105045, Article 105045
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2022
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • Sustainable global immunization campaigns against COVID-19 and other emerging infectious diseases require effective, broadly deployable vaccines. Here, we report a dissolvable microarray patch (MAP) SARS-CoV-2 vaccine that targets the immunoresponsive skin microenvironment, enabling efficacious needle-free immunization. Multicomponent MAPs delivering both SARS-CoV-2 S1 subunit antigen and the TLR3 agonist Poly(I:C) induce robust antibody and cellular immune responses systemically and in the respiratory mucosa. MAP vaccine-induced antibodies bind S1 and the SARS-CoV-2 receptor-binding domain, efficiently neutralize the virus, and persist at high levels for more than a year. The MAP platform reduces systemic toxicity of the delivered adjuvant and maintains vaccine stability without refrigeration. When applied to human skin, MAP vaccines activate skin-derived migratory antigen-presenting cells, supporting the feasibility of human translation. Ultimately, this shelf-stable MAP vaccine improves immunogenicity and safety compared to traditional intramuscular vaccines and offers an attractive alternative for global immunization efforts against a range of infectious pathogens. [Display omitted] •An immunogenic, safe, shelf-stable microarray patch (MAP) SARS-CoV-2 vaccine•Polyfunctional cellular immunity and long-lasting antibody responses•Robust respiratory tract immunity via skin vaccination•Translational immune correlates of MAP SARS-CoV-2 vaccine in human skin Immunology; Virology; Medical biotechnology
Sprache
Englisch
Identifikatoren
ISSN: 2589-0042
eISSN: 2589-0042
DOI: 10.1016/j.isci.2022.105045
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_ecf940f82be949dab711a9d7dd51cc64

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX